| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/09/1997 | WO1997000891A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | WO1997000886A1 Obesity protein intermediates and their preparation and use |
| 01/09/1997 | WO1997000726A1 Silicon-based sleeve devices for chemical reactions |
| 01/09/1997 | WO1997000698A1 Inhibition of hepatitis b replication |
| 01/09/1997 | WO1997000696A1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
| 01/09/1997 | WO1997000695A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | WO1997000691A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | WO1997000690A1 Interleukin-1 receptor-associated protein kinase and assays |
| 01/09/1997 | WO1996040040A3 Thrombin receptor homolog |
| 01/09/1997 | WO1996039511A3 A c5a-like seven transmembrane receptor |
| 01/09/1997 | WO1996039504A3 Methods for distinguishing metastatic and non-metastatic cancers, polynucleotides and polypeptides for use therein |
| 01/09/1997 | WO1996038560A3 Genetic control of flowering |
| 01/09/1997 | WO1996038556A3 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer |
| 01/09/1997 | WO1996034088A3 Control of floral induction in plants and uses therefor |
| 01/09/1997 | WO1996030540A3 Substrates for beta-lactamase and uses thereof |
| 01/09/1997 | DE19523279A1 Verfahren zur mikrobiellen Herstellung von Aminosäuren mittels rekombinanter Mikroorganismen mit erhöhter Sekretionsrate Process for the microbial production of amino acids by recombinant microorganisms with increased secretion |
| 01/09/1997 | CA2226085A1 Aortic preferentially-expressed gene and uses thereof |
| 01/09/1997 | CA2225600A1 Gibberellin-regulated myb polypepetides |
| 01/09/1997 | CA2225517A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | CA2225460A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | CA2225406A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | CA2225401A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | CA2225377A1 Novel tgf-.beta. like cytokine |
| 01/09/1997 | CA2225318A1 Diagnostic test for equine arteritis virus mediated disease |
| 01/09/1997 | CA2224995A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/09/1997 | CA2224872A1 Dna encoding a porcine complement inhibitor |
| 01/09/1997 | CA2224867A1 Obesity protein intermediates and their preparation and use |
| 01/09/1997 | CA2224799A1 A human edg-2 receptor homolog |
| 01/09/1997 | CA2224797A1 Immortalized epithelial tumor cell |
| 01/09/1997 | CA2224719A1 Method and apparatus for determining a mutation |
| 01/09/1997 | CA2224624A1 Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof |
| 01/09/1997 | CA2224477A1 Inhibition of hepatitis b replication |
| 01/09/1997 | CA2224247A1 Human homolog of the mouse rab18 gene |
| 01/09/1997 | CA2222270A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
| 01/08/1997 | EP0752477A2 Expression vectors that produce steroid receptors, steroid receptor chimera, screening assays for steroid receptors and clinical assays using synthesized receptors and receptor vectors |
| 01/08/1997 | EP0752475A1 Modified bacterial alkaline phosphatases and their uses |
| 01/08/1997 | EP0752474A1 Nucleic acid coding for CMP-N-acetyl-neuraminic acid hydroxylase and its use for the production of modified glycoproteins |
| 01/08/1997 | EP0752473A2 Cloning and characterization of H. pylori flbA gene: production of flagella-free strains |
| 01/08/1997 | EP0752472A1 Novel gene originating in corynebacterium and use thereof |
| 01/08/1997 | EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 01/08/1997 | EP0752008A1 Dna mutagenesis by random fragmentation and reassembly |
| 01/08/1997 | EP0752007A1 Thermodynamics, design, and use of nucleic acid sequences |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 01/08/1997 | EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 01/08/1997 | EP0752002A1 Inhibition of arterial smooth muscle cell proliferation |
| 01/08/1997 | EP0752001A1 Biological insect control agent |
| 01/08/1997 | EP0752000A1 Packaging-deficient lentiviruses |
| 01/08/1997 | EP0751999A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors |
| 01/08/1997 | EP0751998A1 A gene expression system utilizing an rna polymerase prebound to dna |
| 01/08/1997 | EP0751997A1 Dna encoding enzymes of the glycolitic pathway for use in alcohol producing yeast |
| 01/08/1997 | EP0751996A1 Luciferases |
| 01/08/1997 | EP0751995A1 Riboflavin synthesis in fungi |
| 01/08/1997 | EP0751994A1 C-terminally truncated cftr genes and proteins |
| 01/08/1997 | EP0751993A1 Dyslipoproteinaemia-sensitised transgenic rabbit |
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
| 01/08/1997 | EP0751986A1 Method for increasing plasmid yield |
| 01/08/1997 | EP0751962A1 Methods and compositions for inhibiting cd14 mediated cell activation |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751955A1 Super proteins including interferons and interleukins |
| 01/08/1997 | EP0751951A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 01/08/1997 | EP0751949A1 Anti-hepatitis b viral oligonucleotides |
| 01/08/1997 | EP0751827A1 Method of processing nucleic acids |
| 01/08/1997 | EP0751788A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
| 01/08/1997 | EP0751786A1 Urease-based vaccine and treatment for helicobacter infection |
| 01/08/1997 | EP0751784A1 Thyroxin-binding proteins |
| 01/08/1997 | EP0751782A1 Methods for altering fertility |
| 01/08/1997 | EP0751781A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | EP0706320B1 Method of controlling insects |
| 01/08/1997 | EP0651814B1 Maize pollen-specific polygalacturonase gene |
| 01/08/1997 | EP0646181B1 Use of nucleic acid analogues in the inhibition of nucleic acid amplification |
| 01/08/1997 | EP0580672B1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN |
| 01/08/1997 | EP0497828B1 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 01/08/1997 | EP0473724B1 A human cytokine, interleukin-9 |
| 01/08/1997 | EP0386166B1 PROTAMINE-REACTIVE IgM ANTIBODIES |
| 01/08/1997 | EP0341273B1 Biological materials, processes for producing biological materials and for using such materials in therapy |
| 01/08/1997 | EP0268636B1 Polynucleotide sequences encoding the human FC RECEPTOR FOR IMMUNOGLOBULIN |
| 01/08/1997 | CN1139956A Process for producing substance |
| 01/08/1997 | CN1139955A Human kunitz-type protease inhibitors |
| 01/08/1997 | CN1139933A Interleukin-6 (iL-6) antagonists |
| 01/08/1997 | CN1139871A Novel apopotsis-modulating proteins, DNA encoding the proteins and methods of use thereof |
| 01/08/1997 | CN1139703A Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell |
| 01/08/1997 | CN1033760C Protein with 8th activity factor, process for its preparation using genetic engineering cell and pharmaceutical composition containing it |
| 01/08/1997 | CN1033759C 猪生长激素类似物 Porcine growth hormone analog |
| 01/07/1997 | US5591872 Regulation of gene expression in pseudomonas, treatment of infection |
| 01/07/1997 | US5591841 Rapid purification of circular DNA by triplex-mediated affinity capture |
| 01/07/1997 | US5591840 Antisense oligonucleotides directed against nucleic acids encoding NFKB transcription factor |
| 01/07/1997 | US5591828 Genetic engineering |
| 01/07/1997 | US5591827 Interleukin-6 receptor antagonists |
| 01/07/1997 | US5591825 Dna and transducers |
| 01/07/1997 | US5591823 Expression of specific immunogens using viral antigens |
| 01/07/1997 | US5591721 Orally administering oligonucleotide with phosphorothioate internucleoside linkage |
| 01/07/1997 | US5591720 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/07/1997 | US5591718 Neutrophil activating factors |
| 01/07/1997 | US5591669 Transgenic mice depleted in a mature lymphocytic cell-type |
| 01/07/1997 | US5591648 Antibodies for mevalonic acid and methods for immunological determination of mevalonic acid by using them |
| 01/07/1997 | US5591640 Functional DNA block and plasmid coding for hirudin, transformed yeast, method for preparing hirudin, hirudin obtained and its pharmaceutical use |
| 01/07/1997 | US5591639 Plasmids and gene expression for dna sequences |
| 01/07/1997 | US5591638 Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of B viral hepatitis, and preparations containing the expression products of said DNAs |